Walgreens (WBA) Hits 52-Week High, Can the Run Continue?
Have you been paying attention to shares of Walgreens Boots Alliance (WBA)? Shares have been on the move with the stock up 6% over the past month. The stock hit a new 52-week high of $83.53 in the previous session. Walgreens Boots Alliance has gained 15% since the start of the year compared to the 4.8% move for the Zacks Retail-Wholesale sector and the 14.5% return for the Zacks Retail - Pharmacies and Drug Stores industry.
What's Driving the Outperformance?
...
https://finance.yahoo.com/news/walgreens...02332.html
Walgreens stock dives after Goldman downgrade on concerns about core business
Goldman’s new stock price target is about 14% below Friday’s trading level
Walgreens Boots Alliance Inc. shares fell 4% Friday, after Goldman Sachs downgraded the stock to sell from neutral, citing concerns about a deteriorating performance at its core retail pharmacy business as reimbursement rates fall and front-end sales decline.
“Challenges in its retail pharmacy business have intensified, forcing the company to search for other avenues of growth,” analysts led by Robert Jones wrote in a note. Goldman lowered its 12-month price target on the stock to $68 from $73, or about 14% below Friday’s trading level.
...
https://www.marketwatch.com/story/walgre...2018-12-14
Walgreens Boots Alliance (WBA) Beats Q1 Earnings and Revenue Estimates
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.28 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 2.10%. A quarter ago, it was expected that this largest U.S. drugstore chain would post earnings of $1.44 per share when it actually produced earnings of $1.48, delivering a surprise of 2.78%.
...
https://finance.yahoo.com/news/walgreens...ccounter=1
WBA -3%
![[Bild: WBAc1dl1003.png]](https://finviz.com/publish/122018/WBAc1dl1003.png)
Walgreens' stock tumbles after profit miss and slashed guidance, as challenges accelerated
...
Net income fell to $1.16 billion, or $1.24 a share, from $1.35 billion, or $1.36 a share, in the same period a year ago. Excluding non-recurring items, adjusted EPS declined 5.4% to $1.64, below the FactSet consensus of $1.72. Sales rose 4.6% to $34.53 billion, just shy of the FactSet consensus of $34.58 billion, as retail pharmacy sales in the U.S. and international were in line with expectations and pharmaceutical wholesale sales missed.
...
https://www.marketwatch.com/story/walgre...latestnews
Walgreens Boots (WBA) Q1 Earnings Lag Estimates, Margins Fall
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $1.37 per share, missing the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $1.46 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -2.14%. A quarter ago, it was expected that this largest U.S. drugstore chain would post earnings of $1.41 per share when it actually produced earnings of $1.43, delivering a surprise of 1.42%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Walgreens, which belongs to the Zacks Retail - Pharmacies and Drug Stores industry, posted revenues of $34.34 billion for the quarter ended November 2019, missing the Zacks Consensus Estimate by 0.84%. This compares to year-ago revenues of $33.79 billion.
...
https://finance.yahoo.com/news/walgreens...01125.html
![[Bild: WBAc1dl1511.png]](https://finviz.com/publish/010820/WBAc1dl1511.png)
Walgreens Boots (WBA) Q3 Earnings Lag Estimates, Margin Down
Walgreens Boots Alliance, Inc. WBA reported adjusted earnings per share (EPS) of 83 cents for third-quarter fiscal 2020, down 43.8% year over year (down 43.4% at constant exchange rate or CER). Also, the figure lagged the Zacks Consensus Estimate by 24.5%.
GAAP loss per share was $1.95 on a year-over-year basis against EPS of $1.13. The U.K. market was the most impacted by COVID-19, which required a review resulting in non-cash impairment charges of $2 billion related to goodwill and intangible assets in Boots UK.
...
https://finance.yahoo.com/news/walgreens...04769.html
![[Bild: WBAc1dl0322.png]](https://finviz.com/publish/071020/WBAc1dl0322.png)